Market Cap 218.40M
Revenue (ttm) 11.16M
Net Income (ttm) -148.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,327.33%
Debt to Equity Ratio 0.00
Volume 1,915,900
Avg Vol 1,360,496
Day's Range N/A - N/A
Shares Out 96.64M
Stochastic %K 38%
Beta 2.46
Analysts Strong Sell
Price Target $18.33

Company Profile

Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Ho...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 982 6030
Address:
2929 7th Street, Suite 105, Berkeley, United States
vu_jade
vu_jade Apr. 24 at 7:48 PM
$CRBU BTFD
0 · Reply
STACKD0E
STACKD0E Apr. 23 at 4:21 PM
0 · Reply
YakoCapital
YakoCapital Apr. 23 at 4:11 PM
0 · Reply
vu_jade
vu_jade Apr. 23 at 2:31 PM
$CCCC $CRBU $CABA Down days are add days …
1 · Reply
Adamchristlover
Adamchristlover Apr. 22 at 10:39 PM
$CRBU $HUMA $ABOS Nice seeing you Jack I am holding HUMA and CRBU
0 · Reply
jacksparo
jacksparo Apr. 22 at 5:36 PM
$CRBU From my email and it’s doing good so far since then $HUMA In my Live Biotech group still holding some . $ABOS Still holding!
0 · Reply
Lrussell234
Lrussell234 Apr. 22 at 4:03 PM
$CRBU Love it 👍
0 · Reply
vu_jade
vu_jade Apr. 22 at 3:21 PM
$CRBU $CABA $CCCC Own them all and will bank on all 3
0 · Reply
Mogeyman
Mogeyman Apr. 22 at 3:07 PM
$CRBU Sell the company for $10/share
1 · Reply
YakoCapital
YakoCapital Apr. 22 at 2:30 PM
$CRBU Steady climb, hopefully we stay up this time.
0 · Reply
Latest News on CRBU
Caribou Biosciences Transcript: Study Result

Nov 3, 2025, 8:00 AM EST - 6 months ago

Caribou Biosciences Transcript: Study Result


vu_jade
vu_jade Apr. 24 at 7:48 PM
$CRBU BTFD
0 · Reply
STACKD0E
STACKD0E Apr. 23 at 4:21 PM
0 · Reply
YakoCapital
YakoCapital Apr. 23 at 4:11 PM
0 · Reply
vu_jade
vu_jade Apr. 23 at 2:31 PM
$CCCC $CRBU $CABA Down days are add days …
1 · Reply
Adamchristlover
Adamchristlover Apr. 22 at 10:39 PM
$CRBU $HUMA $ABOS Nice seeing you Jack I am holding HUMA and CRBU
0 · Reply
jacksparo
jacksparo Apr. 22 at 5:36 PM
$CRBU From my email and it’s doing good so far since then $HUMA In my Live Biotech group still holding some . $ABOS Still holding!
0 · Reply
Lrussell234
Lrussell234 Apr. 22 at 4:03 PM
$CRBU Love it 👍
0 · Reply
vu_jade
vu_jade Apr. 22 at 3:21 PM
$CRBU $CABA $CCCC Own them all and will bank on all 3
0 · Reply
Mogeyman
Mogeyman Apr. 22 at 3:07 PM
$CRBU Sell the company for $10/share
1 · Reply
YakoCapital
YakoCapital Apr. 22 at 2:30 PM
$CRBU Steady climb, hopefully we stay up this time.
0 · Reply
vu_jade
vu_jade Apr. 22 at 12:37 PM
$CRBU will be adding more Caribou to the menu
0 · Reply
STACKD0E
STACKD0E Apr. 22 at 1:31 AM
$CRBU $AKTS 🙃✨️
0 · Reply
Lrussell234
Lrussell234 Apr. 21 at 8:34 PM
$CRBU Something does seem to be brewing here. No intel - just feel. For me, I’ve got a lot of money in here, and if it pops, it’ll be a nice win. We all know trading is not easy. Fighting the algos, MM’s, Naked shorts - it’s a Wild West Casino with few rules. Hard to do. GLTA 👍
0 · Reply
Y007
Y007 Apr. 21 at 3:28 PM
$CRBU 🔥 🔥
0 · Reply
NewEarth
NewEarth Apr. 21 at 2:14 PM
0 · Reply
Lrussell234
Lrussell234 Apr. 21 at 2:00 PM
$CRBU Go Boo! Impressive. 👍
0 · Reply
Mindegap
Mindegap Apr. 20 at 7:50 PM
If I were short I would be nervous right now. Covering would be a very good option. $ABSI, $PRME, $MGX, $CRBU, $MXCT
1 · Reply
Tdorsey1776
Tdorsey1776 Apr. 20 at 7:21 PM
$CRBU Pfizer Inc. (PFE) is the largest strategic holder of shares at 5.04%, which includes a right-of-first-negotiation on BCMA programs. Pfizer got in at $5.33/share and has never once sold. So, although they are quite down on their initial investment, Pfizer still thinks there is something worth holding onto with Caribou. Other institutional investors consist of Renaissance Technologies, BlackRock, and Susquehanna.
0 · Reply
vu_jade
vu_jade Apr. 20 at 6:31 PM
$CRBU sniffing a big news drop coming
0 · Reply
Tdorsey1776
Tdorsey1776 Apr. 20 at 6:13 PM
$CRBU "Caribou is attempting to solve the problems with allogeneic therapies by using its CRISPR hybrid RNA-DNA guide technology, or chRDNA. I know, lots of capital letters jumbled together. Essentially, they are really, really good at precision genome editing in their product. With such power, Caribou can throw out insanely accurate edits to decrease the risk that the T cells attack the patient's good stuff while also decreasing the risk that the patient's immune system kills the therapeutic T cells. They can take on both graft-versus-host disease and host-versus-graft rejection via genome editing. It is truly remarkable technology, the stuff that makes curing cancer not seem so far off."
0 · Reply
ChicagoJoe20
ChicagoJoe20 Apr. 20 at 5:36 PM
$CRBU invivo
2 · Reply
Tdorsey1776
Tdorsey1776 Apr. 20 at 5:22 PM
$CRBU https://www.fiercebiotech.com/biotech/lilly-picks-another-vivo-car-t-company-7b-deal-kelonia
0 · Reply